Latest On Alpine Immune Sciences, Inc (ALPN):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-12 06:01 EST | News | Alpine Immune Sciences GAAP EPS of -$0.28 beats by $0.09, revenue of $9.4M beats by $2.52M | N/A |  |
| 2023-03-29 08:50 EST | News | Alpine Immune: Rebuilding Itself From Scratch, But Long Way To Go Before Proof | N/A | |
| 2023-03-24 06:33 EST | News | Alpine Immune Sciences GAAP EPS of -$0.41 misses by $0.14, revenue of $2.78M misses by $8.18M | N/A | |
| 2023-03-24 06:33 EST | News | Alpine Immune Sciences, Inc. (ALPN) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-22 23:18 EST | News | Alpine Immune Sciences Q4 2022 Earnings Preview | N/A | |
| 2023-01-19 15:46 EST | News | Alpine Immune wins bullish views at Morgan Stanley on lead program | N/A | |
| 2022-11-14 22:08 EST | News | Alpine Immune Sciences GAAP EPS of -$0.42 misses by $0.32, revenue of $8.37M misses by $10.31M | N/A | |
| 2022-11-14 22:08 EST | News | Alpine Immune Sciences, Inc. (ALPN) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-12 00:39 EST | News | Alpine Immune Sciences Q3 2022 Earnings Preview | N/A | |
| 2022-10-27 21:26 EST | News | Alpine: Ramifications Of The Davoceticept Termination | N/A | |
| 2022-10-27 21:25 EST | News | Alpine Immune Sciences: ALPN-202 May Be Dead, But The Company Isn't | N/A | |
| 2022-10-24 18:20 EST | News | Alpine Immune ends enrollments for cancer studies after patient death | N/A | |
| 2022-09-21 04:34 EST | News | Alpine Immune Sciences drops 13% after hours on $100M stock offering | N/A | |
| 2022-09-21 04:34 EST | News | Alpine Immune Sciences prices $100M stock offering | N/A | |
| 2022-08-11 22:35 EST | News | Alpine Immune Sciences GAAP EPS of -$0.60 misses by $0.21, revenue of $5.29M misses by $4.75M | N/A | |
| 2022-08-10 12:06 EST | News | Evotec stock falls amid pact with Alpine for commercial process for potential lupus drug ALPN-303 | N/A | |
| 2022-06-08 00:04 EST | News | Andrew S. Sandler is the new chief medical officer of Alpine Immune | N/A | |
| 2022-05-24 13:14 EST | News | FDA lifts partial clinical hold on Alpine Immune's davoceticept for malignancies | N/A | |
| 2022-05-13 06:49 EST | News | Alpine Immune Sciences GAAP EPS of -$0.25, revenue of $13.63M | N/A | |
| 2022-04-25 17:20 EST | News | Alpine: Rest Before Rallying Again | N/A | |
| 2022-03-18 11:15 EST | News | Alpine Immune Sciences GAAP EPS of -$0.52 misses by $0.22, revenue of $4.53M misses by $9.44M | N/A | |
| 2022-03-07 15:24 EST | News | Partial clinical hold placed on Alpine Immune's davoceticept for malignancies | N/A | |
| 2021-12-16 22:17 EST | News | Alpine Immune, Horizon Therapeutics team up to develop therapies for autoimmune and inflammatory diseases | N/A | |
| 2021-11-11 00:43 EST | News | Alpine Immune Sciences EPS misses by $0.56, misses on revenue | N/A | |
| 2021-09-22 20:46 EST | News | MRIN, ALPN, SMMT and LPTX among after hours movers | N/A | |
| 2021-09-17 12:49 EST | News | Alpine Immune secures $91M through equity offering | N/A | |
| 2021-08-12 11:57 EST | News | Alpine Immune Sciences (ALPN) Investor Presentation | N/A | |
| 2021-08-11 15:56 EST | News | Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-10 19:56 EST | News | Alpine Immune Sciences EPS misses by $0.12, misses on revenue | N/A | |
| 2021-07-20 18:38 EST | News | Alpine Immune Sciences files for $150M mixed shelf offering | N/A | |
| 2021-07-20 18:35 EST | News | Alpine Immune Sciences: Better Days Ahead | N/A | |
| 2021-07-20 18:33 EST | News | Alpine Immune releases promising early data on lupus candidate | N/A | |
| 2021-07-20 18:22 EST | News | Alpine Immune shares rise on clinical trial collaboration agreement with Merck | N/A | |
| 2021-04-16 08:52 EST | News | Alpine Immune Sciences Is A Blind Buy After The Recent Price Decrease | N/A | |
| 2021-03-19 11:35 EST | News | Alpine Immune Sciences EPS beats by $0.04, beats on revenue | N/A | |
| 2021-03-19 11:29 EST | News | Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-19 04:07 EST | Earnings Estimate | An EPS average of -$0.86 is estimated for the 2022 year. | Sell | |
| 2021-03-19 04:07 EST | Earnings Estimate | An EPS average of -$0.27 is estimated for the quarter ending on June 30, 2021. | N/A | |
| 2021-01-06 02:19 EST | News | Alpine: Is This A Young Oak Tree? | N/A | |
| 2020-12-22 19:05 EST | Analyst Rating | The Analyst Target Price has decreased from $21.5 to $21.4. | Neutral | |
| 2020-12-13 03:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-11 15:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-25 11:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-17 11:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-13 20:38 EST | News | Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-13 03:09 EST | Earnings Estimate | An EPS average of -$0.08 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-11-12 16:24 EST | News | Alpine Immune Sciences EPS misses by $0.05, misses on revenue | N/A | |
| 2020-11-01 16:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 04:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-22 04:04 EST | Financials | Company financials have been released. | Neutral | |
About Alpine Immune Sciences, Inc (ALPN):
Alpine Immune Sciences, Inc. focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its lead programs include ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; and ALPN-202, a programmed cell death protein ligand 1 (PD-L1)/cytotoxic T-lymphocyte associated protein 4 (CTLA-4) antagonist with PD-L1 dependent CD28 costimulation for the treatment of cancer. The company has a collaboration and licensing agreement with the Kite Pharma, Inc. for discovering and developing protein-based immunotherapies targeting the immune synapse to treat cancer. Alpine Immune Sciences, Inc. is headquartered in Seattle, Washington.
General
- Name Alpine Immune Sciences, Inc
- Symbol ALPN
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 53
- Last Split Factor1:4
- Last Split Date2017-07-25
- Fiscal Year EndDecember
- IPO Date2015-06-17
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.alpineimmunesciences.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 59.37
- Price/Book (Most Recent Quarter) 4.91
- Enterprise Value Revenue 46.44
View More
Financials
- Most Recent Quarter 2020-09-30
- Current Year EPS Estimate -$0.73
- Next Year EPS Estimate -$0.86
- Next Quarter EPS Estimate -$0.26
- Operating Margin -640%
- Return on Assets -17%
- Return on Equity -54%
- Revenue 4.58 million
- Earnings Per Share -$2.97
- Revenue Per Share $0.23
- Gross Profit -34107000
- Quarterly Earnings Growth 561.9%
View More
Highlights
- Market Capitalization 328.72 million
- EBITDA -48231000
- PE Ratio -131.59
- Analyst Target Price $21.4
- Book Value Per Share $2.83
View More
Share Statistics
- Shares Outstanding 23.8 million
- Shares Float 8.66 million
- % Held by Insiders 2849%
- % Held by Institutions 52.56%
- Shares Short 385513
- Shares Short Prior Month 377164
- Short Ratio 2.78
- Short % of Float 4%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 1.73
- 52 Week High $16.37
- 52 Week Low $2.1
- 50 Day Moving Average 12.51
- 200 Day Moving Average 10.57
View More
Dividends
- Dividend Date 2017-07-25
- ExDividend Date N/A
- Dividend Yield 0%
View More
Alpine Immune Sciences, Inc (ALPN) Dividend Calendar:
ALPN's last dividend payment was made to shareholders on July 25, 2017.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Alpine Immune Sciences, Inc (ALPN) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2020-12-31 | -$0.27 | -$0.31 | 12.9% | |
| 2020-09-30 | 2020-11-12 | $1.91 million | -$0.28 | -$0.23 | -20.43% |
| 2020-06-30 | 2020-08-11 | $N/A | -$0.53 | $0.54 | -199.07% |
| 2020-03-31 | 2020-05-14 | $1.09 million | -$0.30 | -$0.47 | 36.17% |
| 2019-12-31 | 2020-03-30 | $884000 | -$0.33 | -$0.59 | 43.59% |
| 2019-09-30 | 2019-11-13 | $289000 | -$0.62 | -$0.68 | 8.82% |
| 2019-06-30 | 2019-08-13 | $567000 | -$0.64 | -$0.68 | 5.54% |
| 2019-03-31 | 2019-05-09 | $N/A | -$0.70 | -$0.69 | -1.45% |
| 2018-12-31 | 2019-03-18 | $705000 | -$0.80 | -$0.80 | -0.25% |
| 2018-09-30 | 2018-11-08 | $-390000 | -$0.88 | -$0.57 | -55.48% |
| 2018-06-30 | 2018-08-09 | $390000 | -$0.57 | -$0.43 | -31.55% |
| 2018-03-31 | 2018-05-14 | $315000 | -$0.38 | -$0.40 | 3.8% |
| 2017-12-31 | 2018-03-28 | $1.6 million | -$0.33 | -$0.37 | 9.59% |
| 2017-09-30 | 2017-11-13 | $128000 | $0.18 | -$0.28 | 164.29% |
| 2017-06-30 | 2017-09-29 | $738000 | -$5.40 | -$2.19 | -146.58% |
| 2017-03-31 | 2017-05-01 | $737000 | -$2.28 | -$1.90 | -20% |
| 2016-12-31 | 2017-02-13 | $2.95 million | -$2.00 | -$2.20 | 9.09% |
| 2016-09-30 | 2016-11-07 | $N/A | -$1.92 | -$2.37 | 18.99% |
| 2016-06-30 | 2016-08-01 | $N/A | -$2.20 | -$2.09 | -5.26% |
| 2016-03-31 | 2016-05-02 | $N/A | -$2.04 | -$1.76 | -15.91% |
| 2015-12-31 | 2016-02-29 | -$1.68 | -$1.43 | -17.48% | |
| 2015-09-30 | 2015-11-02 | $N/A | -$1.56 | -$1.66 | 6.02% |
| 2015-06-30 | 2015-08-03 | $N/A | -$1.41 | -$0.41 | -243.9% |
Alpine Immune Sciences, Inc (ALPN) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Alpine Immune Sciences, Inc (ALPN) Chart:
Alpine Immune Sciences, Inc (ALPN) News:
Below you will find a list of latest news for Alpine Immune Sciences, Inc (ALPN) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Alpine Immune Sciences, Inc (ALPN) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0 | CALL | 0 | 0 | 1305.04 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 927.12 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 754.45 | TRUE | 0 | 0 |
| 2024-05-17 | 10 | 54.4 | CALL | 0 | 3 | 644.23 | TRUE | 0 | 0 |
| 2024-05-17 | 12.5 | 14.97 | CALL | 0 | 9 | 563.91 | TRUE | 0 | 0 |
| 2024-05-17 | 15 | 31.4 | CALL | 0 | 5 | 500.96 | TRUE | 0 | 0 |
| 2024-05-17 | 17.5 | 22.8 | CALL | 0 | 5 | 411.92 | TRUE | 0 | 0 |
| 2024-05-17 | 20 | 44.5 | CALL | 0 | 35 | 405.51 | TRUE | 0 | 0 |
| 2024-05-17 | 22.5 | 5.98 | CALL | 0 | 0 | 367.5 | TRUE | 0 | 0 |
| 2024-05-17 | 25 | 39.8 | CALL | 0 | 47 | 338.25 | TRUE | 0 | 0 |
| 2024-05-17 | 30 | 34.73 | CALL | 0 | 1124 | 188.14 | TRUE | 0 | 0 |
| 2024-05-17 | 35 | 29.78 | CALL | 0 | 263 | 151.78 | TRUE | 0 | 0 |
| 2024-05-17 | 40 | 24.43 | CALL | 0 | 545 | 120.38 | TRUE | 0 | 0 |
| 2024-05-17 | 45 | 19.5 | CALL | 0 | 341 | 57.42 | TRUE | 0 | 0 |
| 2024-05-17 | 50 | 14.7 | CALL | 0 | 169 | 59.76 | TRUE | 0 | 0 |
| 2024-05-17 | 55 | 9.76 | CALL | 0 | 133 | 38.25 | TRUE | 0 | 0 |
| 2024-05-17 | 60 | 4.93 | CALL | 0 | 12 | 18.55 | TRUE | 0 | 0 |
| 2024-05-17 | 65 | 0.05 | CALL | 11 | 10585 | 2.74 | FALSE | 0 | 0 |
| 2024-05-17 | 70 | 0.05 | CALL | 0 | 198 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 75 | 0.05 | CALL | 0 | 37 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 80 | 0.15 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 85 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 90 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 95 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 10 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 12.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 15 | 0.35 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 17.5 | 0.04 | PUT | 0 | 11 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 20 | 0.05 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 22.5 | 0.4 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 25 | 0.05 | PUT | 0 | 505 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 30 | 0.05 | PUT | 0 | 883 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 35 | 0.05 | PUT | 0 | 530 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 40 | 0.05 | PUT | 0 | 819 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 45 | 0.05 | PUT | 0 | 409 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 50 | 0.01 | PUT | 0 | 1149 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 55 | 0.05 | PUT | 0 | 99 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 60 | 0.1 | PUT | 1 | 1743 | 25.43 | FALSE | 0.05 | 1 |
| 2024-05-17 | 65 | 0.4 | PUT | 4 | 172 | 6.26 | TRUE | 0 | 0 |
| 2024-05-17 | 70 | 8 | PUT | 0 | 1 | 34.35 | TRUE | 0 | 0 |
| 2024-05-17 | 75 | 0 | PUT | 0 | 0 | 55.95 | TRUE | 0 | 0 |
| 2024-05-17 | 80 | 0 | PUT | 0 | 0 | 72.98 | TRUE | 0 | 0 |
| 2024-05-17 | 85 | 0 | PUT | 0 | 0 | 121.8 | TRUE | 0 | 0 |
| 2024-05-17 | 90 | 0 | PUT | 0 | 0 | 136.43 | TRUE | 0 | 0 |
| 2024-05-17 | 95 | 0 | PUT | 0 | 0 | 151.2 | TRUE | 0 | 0 |
| 2024-06-21 | 35 | 0 | CALL | 0 | 0 | 116.99 | TRUE | 0 | 0 |
| 2024-06-21 | 40 | 0 | CALL | 0 | 0 | 97.85 | TRUE | 0 | 0 |
| 2024-06-21 | 45 | 0 | CALL | 0 | 0 | 78.84 | TRUE | 0 | 0 |
| 2024-06-21 | 50 | 0 | CALL | 0 | 0 | 60.13 | TRUE | 0 | 0 |
| 2024-06-21 | 55 | 0 | CALL | 0 | 0 | 47.48 | TRUE | 0 | 0 |
| 2024-06-21 | 60 | 0 | CALL | 0 | 0 | 29.6 | TRUE | 0 | 0 |
| 2024-06-21 | 65 | 0.05 | CALL | 50 | 1280 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 70 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 75 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 80 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 85 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 90 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 95 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 35 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 40 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 45 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 50 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 55 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 60 | 0.15 | PUT | 232 | 4 | 16.12 | FALSE | 0 | 0 |
| 2024-06-21 | 65 | 0.45 | PUT | 0 | 5 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 70 | 0 | PUT | 0 | 0 | 33.39 | TRUE | 0 | 0 |
| 2024-06-21 | 75 | 0 | PUT | 0 | 0 | 45.79 | TRUE | 0 | 0 |
| 2024-06-21 | 80 | 0 | PUT | 0 | 0 | 53.97 | TRUE | 0 | 0 |
| 2024-06-21 | 85 | 0 | PUT | 0 | 0 | 63.9 | TRUE | 0 | 0 |
| 2024-06-21 | 90 | 0 | PUT | 0 | 0 | 69.71 | TRUE | 0 | 0 |
| 2024-06-21 | 95 | 0 | PUT | 0 | 0 | 69.68 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 0 | CALL | 0 | 0 | 487.95 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 0 | CALL | 0 | 0 | 344.07 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | CALL | 0 | 0 | 277.85 | TRUE | 0 | 0 |
| 2024-08-16 | 10 | 0 | CALL | 0 | 0 | 235.36 | TRUE | 0 | 0 |
| 2024-08-16 | 12.5 | 0 | CALL | 0 | 0 | 204.27 | TRUE | 0 | 0 |
| 2024-08-16 | 15 | 0 | CALL | 0 | 0 | 179.83 | TRUE | 0 | 0 |
| 2024-08-16 | 17.5 | 12.85 | CALL | 0 | 5 | 159.72 | TRUE | 0 | 0 |
| 2024-08-16 | 20 | 45.65 | CALL | 0 | 4 | 140.3 | TRUE | 0 | 0 |
| 2024-08-16 | 22.5 | 4.5 | CALL | 0 | 9 | 130 | TRUE | 0 | 0 |
| 2024-08-16 | 25 | 6.6 | CALL | 0 | 4 | 116.8 | TRUE | 0 | 0 |
| 2024-08-16 | 30 | 34.4 | CALL | 0 | 10 | 94.29 | TRUE | 0 | 0 |
| 2024-08-16 | 35 | 30.3 | CALL | 0 | 18 | 60.11 | TRUE | 0 | 0 |
| 2024-08-16 | 40 | 25 | CALL | 0 | 6 | 87.57 | TRUE | 0 | 0 |
| 2024-08-16 | 45 | 19.56 | CALL | 0 | 32 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 50 | 14.6 | CALL | 0 | 270 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 55 | 9.8 | CALL | 0 | 572 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 60 | 4.9 | CALL | 0 | 398 | 15.97 | TRUE | 0 | 0 |
| 2024-08-16 | 65 | 0.05 | CALL | 20 | 6251 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 70 | 0.05 | CALL | 0 | 646 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 75 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 80 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 85 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 90 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 95 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 5 | 0.02 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 10 | 0.38 | PUT | 0 | 8 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 12.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 15 | 0.42 | PUT | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 17.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 20 | 4.7 | PUT | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 22.5 | 1.06 | PUT | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 25 | 1.24 | PUT | 0 | 8 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 30 | 0.05 | PUT | 0 | 33 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 35 | 0.1 | PUT | 0 | 7 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 40 | 0.05 | PUT | 0 | 704 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 45 | 0.01 | PUT | 0 | 102 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 50 | 0.1 | PUT | 0 | 84 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 55 | 0.2 | PUT | 0 | 117 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 60 | 0.15 | PUT | 0 | 5069 | 11.33 | FALSE | 0 | 0 |
| 2024-08-16 | 65 | 0.35 | PUT | 0 | 210 | 5.12 | TRUE | 0 | 0 |
| 2024-08-16 | 70 | 5.6 | PUT | 0 | 1 | 25.18 | TRUE | 0 | 0 |
| 2024-08-16 | 75 | 10.6 | PUT | 0 | 1 | 26.21 | TRUE | 0 | 0 |
| 2024-08-16 | 80 | 0 | PUT | 0 | 0 | 33.69 | TRUE | 0 | 0 |
| 2024-08-16 | 85 | 0 | PUT | 0 | 0 | 40.35 | TRUE | 0 | 0 |
| 2024-08-16 | 90 | 0 | PUT | 0 | 0 | 46.41 | TRUE | 0 | 0 |
| 2024-08-16 | 95 | 0 | PUT | 0 | 0 | 52 | TRUE | 0 | 0 |
| 2024-11-15 | 20 | 20 | CALL | 0 | 0 | 97.72 | TRUE | 0 | 0 |
| 2024-11-15 | 22.5 | 0 | CALL | 0 | 0 | 85.9 | TRUE | 0 | 0 |
| 2024-11-15 | 25 | 13.5 | CALL | 0 | 0 | 75.28 | TRUE | 0 | 0 |
| 2024-11-15 | 30 | 35.65 | CALL | 0 | 28 | 56.34 | TRUE | 0 | 0 |
| 2024-11-15 | 35 | 12.43 | CALL | 0 | 1 | 37.07 | TRUE | 0 | 0 |
| 2024-11-15 | 40 | 24.66 | CALL | 0 | 4 | 58.7 | TRUE | 0 | 0 |
| 2024-11-15 | 45 | 19.6 | CALL | 0 | 6 | 46.13 | TRUE | 0 | 0 |
| 2024-11-15 | 50 | 14.6 | CALL | 0 | 3 | 34.92 | TRUE | 0 | 0 |
| 2024-11-15 | 55 | 9.9 | CALL | 0 | 209 | 24.74 | TRUE | 0 | 0 |
| 2024-11-15 | 60 | 5 | CALL | 0 | 513 | 0 | TRUE | 0 | 0 |
| 2024-11-15 | 65 | 0.08 | CALL | 53 | 1035 | 0 | FALSE | -0.02 | -0.2 |
| 2024-11-15 | 70 | 0.15 | CALL | 0 | 67 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 75 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 80 | 0.1 | CALL | 0 | 26 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 85 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 90 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 95 | 0.15 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 20 | 0.05 | PUT | 0 | 30 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 22.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 25 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 30 | 0.1 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 35 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 40 | 0.13 | PUT | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 45 | 0.15 | PUT | 0 | 71 | 28.96 | FALSE | 0 | 0 |
| 2024-11-15 | 50 | 0.05 | PUT | 0 | 21 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 55 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 60 | 0.05 | PUT | 2 | 2387 | 7.61 | FALSE | -0.1 | -0.67 |
| 2024-11-15 | 65 | 0.55 | PUT | 0 | 137 | 4.01 | TRUE | 0 | 0 |
| 2024-11-15 | 70 | 0 | PUT | 0 | 0 | 20.71 | TRUE | 0 | 0 |
| 2024-11-15 | 75 | 0 | PUT | 0 | 0 | 21.53 | TRUE | 0 | 0 |
| 2024-11-15 | 80 | 0 | PUT | 0 | 0 | 27.5 | TRUE | 0 | 0 |
| 2024-11-15 | 85 | 0 | PUT | 0 | 0 | 33.51 | TRUE | 0 | 0 |
| 2024-11-15 | 90 | 0 | PUT | 0 | 0 | 38.39 | TRUE | 0 | 0 |
| 2024-11-15 | 95 | 0 | PUT | 0 | 0 | 42.89 | TRUE | 0 | 0 |
Latest ALPN Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:57 PM EST | 19 | $8.61 |
| Jun 13, 2022 7:57 PM EST | 6 | $8.6 |
| Jun 13, 2022 7:57 PM EST | 100 | $8.61 |
| Jun 13, 2022 7:59 PM EST | 15 | $8.585 |
| Jun 13, 2022 7:59 PM EST | 1 | $8.585 |
Alpine Immune Sciences, Inc (ALPN) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320018177/0000899243-20-018177-index.htm |
| 2020-07-15 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1626199/000000000020006420/0000000000-20-006420-index.htm |
| 2020-08-13 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1626199/000000000020007443/0000000000-20-007443-index.htm |
| 2018-04-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924318010650/0000899243-18-010650-index.htm |
| 2018-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924318010652/0000899243-18-010652-index.htm |
| 2018-08-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924318021736/0000899243-18-021736-index.htm |
| 2018-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924318021737/0000899243-18-021737-index.htm |
| 2018-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924318025713/0000899243-18-025713-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319000496/0000899243-19-000496-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319000497/0000899243-19-000497-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319000498/0000899243-19-000498-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319000499/0000899243-19-000499-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319000500/0000899243-19-000500-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319000503/0000899243-19-000503-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319001661/0000899243-19-001661-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319001662/0000899243-19-001662-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319001663/0000899243-19-001663-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319003030/0000899243-19-003030-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319003031/0000899243-19-003031-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319003032/0000899243-19-003032-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319003038/0000899243-19-003038-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924319015346/0000899243-19-015346-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320000637/0000899243-20-000637-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320000638/0000899243-20-000638-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320000639/0000899243-20-000639-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320000640/0000899243-20-000640-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320000641/0000899243-20-000641-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320000642/0000899243-20-000642-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320000643/0000899243-20-000643-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320002067/0000899243-20-002067-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320002068/0000899243-20-002068-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320002069/0000899243-20-002069-index.htm |
| 2020-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320018172/0000899243-20-018172-index.htm |
| 2020-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320018173/0000899243-20-018173-index.htm |
| 2020-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320018177/0000899243-20-018177-index.htm |
| 2020-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000089924320018864/0000899243-20-018864-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000091957419001006/0000919574-19-001006-index.htm |
| 2019-01-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1626199/000092189519000160/0000921895-19-000160-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1626199/000092189520000527/0000921895-20-000527-index.htm |
| 2018-01-26 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626199/000094787118000053/0000947871-18-000053-index.htm |
| 2018-01-26 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626199/000094787118000060/0000947871-18-000060-index.htm |
| 2019-01-23 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626199/000094787119000042/0000947871-19-000042-index.htm |
| 2019-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000094787119000043/0000947871-19-000043-index.htm |
| 2019-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000094787119000044/0000947871-19-000044-index.htm |
| 2020-07-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626199/000094787120000655/0000947871-20-000655-index.htm |
| 2019-01-24 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626199/000114420419002677/0001144204-19-002677-index.htm |
| 2018-03-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000119312518098445/0001193125-18-098445-index.htm |
| 2018-03-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1626199/000119312518098624/0001193125-18-098624-index.htm |
| 2018-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1626199/000119312518127697/0001193125-18-127697-index.htm |
| 2018-04-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1626199/000119312518127706/0001193125-18-127706-index.htm |
| 2018-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000119312518127833/0001193125-18-127833-index.htm |
| 2018-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000119312518162515/0001193125-18-162515-index.htm |
| 2018-06-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1626199/000119312518189391/0001193125-18-189391-index.htm |
| 2018-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000119312518189404/0001193125-18-189404-index.htm |
| 2018-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000119312518192903/0001193125-18-192903-index.htm |
| 2018-06-21 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1626199/000119312518199598/0001193125-18-199598-index.htm |
| 2018-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000119312518238992/0001193125-18-238992-index.htm |
| 2018-09-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000119312518281909/0001193125-18-281909-index.htm |
| 2019-01-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000119312519010606/0001193125-19-010606-index.htm |
| 2019-01-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000119312519012912/0001193125-19-012912-index.htm |
| 2019-01-23 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626199/000119312519014154/0001193125-19-014154-index.htm |
| 2019-01-23 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626199/000119312519014248/0001193125-19-014248-index.htm |
| 2019-02-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000119312519032222/0001193125-19-032222-index.htm |
| 2020-07-31 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626199/000119312520204703/0001193125-20-204703-index.htm |
| 2020-08-03 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626199/000119312520206868/0001193125-20-206868-index.htm |
| 2020-08-03 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626199/000119312520206870/0001193125-20-206870-index.htm |
| 2020-08-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1626199/000119312520211999/0001193125-20-211999-index.htm |
| 2018-08-20 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1626199/000119380518001083/0001193805-18-001083-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000120919119004779/0001209191-19-004779-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000120919119004783/0001209191-19-004783-index.htm |
| 2019-01-23 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000120919119005067/0001209191-19-005067-index.htm |
| 2019-01-23 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000120919119005068/0001209191-19-005068-index.htm |
| 2019-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1626199/000120919119005069/0001209191-19-005069-index.htm |
| 2018-03-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1626199/000156459018006916/0001564590-18-006916-index.htm |
| 2018-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626199/000162619918000004/0001626199-18-000004-index.htm |
| 2018-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619918000010/0001626199-18-000010-index.htm |
| 2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626199/000162619918000012/0001626199-18-000012-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619918000016/0001626199-18-000016-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626199/000162619918000018/0001626199-18-000018-index.htm |
| 2019-01-30 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000001/0001626199-19-000001-index.htm |
| 2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000007/0001626199-19-000007-index.htm |
| 2019-03-18 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000010/0001626199-19-000010-index.htm |
| 2019-03-18 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000012/0001626199-19-000012-index.htm |
| 2019-03-18 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000014/0001626199-19-000014-index.htm |
| 2019-03-18 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000016/0001626199-19-000016-index.htm |
| 2019-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000019/0001626199-19-000019-index.htm |
| 2019-04-02 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000022/0001626199-19-000022-index.htm |
| 2019-04-05 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000024/0001626199-19-000024-index.htm |
| 2019-04-11 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000026/0001626199-19-000026-index.htm |
| 2019-04-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000029/0001626199-19-000029-index.htm |
| 2019-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000034/0001626199-19-000034-index.htm |
| 2019-04-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000035/0001626199-19-000035-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000038/0001626199-19-000038-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000040/0001626199-19-000040-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000043/0001626199-19-000043-index.htm |
| 2019-05-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000046/0001626199-19-000046-index.htm |
| 2019-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000049/0001626199-19-000049-index.htm |
| 2019-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000053/0001626199-19-000053-index.htm |
| 2019-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000055/0001626199-19-000055-index.htm |
| 2019-08-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000060/0001626199-19-000060-index.htm |
| 2019-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000064/0001626199-19-000064-index.htm |
| 2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626199/000162619919000067/0001626199-19-000067-index.htm |
| 2020-01-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000003/0001626199-20-000003-index.htm |
| 2020-03-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000008/0001626199-20-000008-index.htm |
| 2020-03-30 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000009/0001626199-20-000009-index.htm |
| 2020-03-30 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000011/0001626199-20-000011-index.htm |
| 2020-05-05 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000014/0001626199-20-000014-index.htm |
| 2020-05-05 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000015/0001626199-20-000015-index.htm |
| 2020-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000019/0001626199-20-000019-index.htm |
| 2020-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000020/0001626199-20-000020-index.htm |
| 2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000024/0001626199-20-000024-index.htm |
| 2020-06-17 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000026/0001626199-20-000026-index.htm |
| 2020-06-18 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000030/0001626199-20-000030-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000031/0001626199-20-000031-index.htm |
| 2020-07-08 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000033/0001626199-20-000033-index.htm |
| 2020-07-14 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000035/0001626199-20-000035-index.htm |
| 2020-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000037/0001626199-20-000037-index.htm |
| 2020-08-07 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000038/0001626199-20-000038-index.htm |
| 2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000043/0001626199-20-000043-index.htm |
| 2020-08-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000045/0001626199-20-000045-index.htm |
| 2020-08-11 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000047/0001626199-20-000047-index.htm |
| 2020-08-14 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000049/0001626199-20-000049-index.htm |
| 2020-08-19 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1626199/000162619920000052/0001626199-20-000052-index.htm |
| 2019-04-04 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1626199/999999999519000606/9999999995-19-000606-index.htm |
| 2020-07-16 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1626199/999999999520001835/9999999995-20-001835-index.htm |
| 2020-08-18 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1626199/999999999520002196/9999999995-20-002196-index.htm |
| 2019-03-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1626199/999999999719001523/9999999997-19-001523-index.htm |
| 2019-03-29 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1626199/999999999719002103/9999999997-19-002103-index.htm |
Alpine Immune Sciences, Inc (ALPN) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alpine Immune Sciences, Inc (ALPN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 2849%Institutional Ownership: 5256%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-05-30 | James Paul Rickey | Senior VP and CFO | Buy | 10,000.00 | 4.95 | 49,500.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1626199/000089924319015346/0000899243-19-015346-index.htm |
| 2019-02-08 | MANAGEMENT L.L.C. TIGER | 10% Share Holder | Sell | 25,000.00 | 5.85 | 146,245.00 | 137,728.00 | https://www.sec.gov/Archives/edgar/data/1626199/000091957419001006/0000919574-19-001006-index.htm |
| 2019-01-18 | Frazier Life Sciences VIII, L.P. | 10% Share Holder | Buy | 372,439.00 | 5.37 | 1,999,997.43 | 2,571,450.00 | https://www.sec.gov/Archives/edgar/data/1626199/000120919119004783/0001209191-19-004783-index.htm |
| 2019-01-18 | James N Topper | Director | Buy | 372,439.00 | 5.37 | 1,999,997.43 | 2,571,450.00 | https://www.sec.gov/Archives/edgar/data/1626199/000120919119004779/0001209191-19-004779-index.htm |
| 2020-01-23 | James Paul Rickey | Senior VP and CFO | Buy | 18,543.00 | 28,543.00 | https://www.sec.gov/Archives/edgar/data/1626199/000089924320002069/0000899243-20-002069-index.htm | ||
| 2019-01-18 | Xiangmin Cui | Director | Buy | 3,165,735.00 | 5.37 | 16,999,996.95 | 3,165,735.00 | https://www.sec.gov/Archives/edgar/data/1626199/000120919119005069/0001209191-19-005069-index.htm |
| 2020-01-23 | STANFORD L PENG | President & Head of R&D | Buy | 32,217.00 | 32,217.00 | https://www.sec.gov/Archives/edgar/data/1626199/000089924320002068/0000899243-20-002068-index.htm | ||
| 2019-01-18 | ORBIMED ADVISORS LLC | Director | Buy | 372,439.00 | 5.37 | 1,999,997.43 | 3,670,955.00 | https://www.sec.gov/Archives/edgar/data/1626199/000094787119000043/0000947871-19-000043-index.htm |
| 2019-01-18 | Peter A. Thompson | Director | Buy | 372,439.00 | 5.37 | 1,999,997.43 | 3,670,955.00 | https://www.sec.gov/Archives/edgar/data/1626199/000094787119000044/0000947871-19-000044-index.htm |
| 2019-01-18 | Alpine ImmunoSciences, L.P. | 10% Share Holder | Buy | 190,875.00 | 5.37 | 1,024,998.75 | 3,994,781.00 | https://www.sec.gov/Archives/edgar/data/1626199/000089924319001663/0000899243-19-001663-index.htm |
| 2019-01-18 | Jay Venkatesan | Director | Buy | 190,875.00 | 5.37 | 1,024,998.75 | 3,994,781.00 | https://www.sec.gov/Archives/edgar/data/1626199/000089924319001661/0000899243-19-001661-index.htm |
| 2019-01-18 | MITCHELL GOLD | Executive Chairman and CEO | Buy | 190,875.00 | 5.37 | 1,024,998.75 | 3,994,781.00 | https://www.sec.gov/Archives/edgar/data/1626199/000089924319001662/0000899243-19-001662-index.htm |
| 2020-01-23 | MITCHELL GOLD | Executive Chairman and CEO | Buy | 67,569.00 | 68,861.00 | https://www.sec.gov/Archives/edgar/data/1626199/000089924320002067/0000899243-20-002067-index.htm |